table of content
1 Introduction to Research & Analysis Reports
1.1 PD-1 and PD-L1 Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PD-1 and PD-L1 Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global PD-1 and PD-L1 Drug Overall Market Size
2.1 Global PD-1 and PD-L1 Drug Market Size: 2023 VS 2030
2.2 Global PD-1 and PD-L1 Drug Revenue, Prospects & Forecasts: 2019-2030
2.3 Global PD-1 and PD-L1 Drug Sales: 2019-2030
3 Company Landscape
3.1 Top PD-1 and PD-L1 Drug Players in Global Market
3.2 Top Global PD-1 and PD-L1 Drug Companies Ranked by Revenue
3.3 Global PD-1 and PD-L1 Drug Revenue by Companies
3.4 Global PD-1 and PD-L1 Drug Sales by Companies
3.5 Global PD-1 and PD-L1 Drug Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 PD-1 and PD-L1 Drug Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers PD-1 and PD-L1 Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 PD-1 and PD-L1 Drug Players in Global Market
3.8.1 List of Global Tier 1 PD-1 and PD-L1 Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 PD-1 and PD-L1 Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global PD-1 and PD-L1 Drug Market Size Markets, 2023 & 2030
4.1.2 PD-1 Monoclonal Antibody
4.1.3 PD-L1 Monoclonal Antibody
4.2 By Type - Global PD-1 and PD-L1 Drug Revenue & Forecasts
4.2.1 By Type - Global PD-1 and PD-L1 Drug Revenue, 2019-2024
4.2.2 By Type - Global PD-1 and PD-L1 Drug Revenue, 2025-2030
4.2.3 By Type - Global PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
4.3 By Type - Global PD-1 and PD-L1 Drug Sales & Forecasts
4.3.1 By Type - Global PD-1 and PD-L1 Drug Sales, 2019-2024
4.3.2 By Type - Global PD-1 and PD-L1 Drug Sales, 2025-2030
4.3.3 By Type - Global PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
4.4 By Type - Global PD-1 and PD-L1 Drug Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global PD-1 and PD-L1 Drug Market Size, 2023 & 2030
5.1.2 Liver Cancer
5.1.3 Esophageal Cancer
5.1.4 Nasal Cancer
5.1.5 Stomach Cancer
5.1.6 Other
5.2 By Application - Global PD-1 and PD-L1 Drug Revenue & Forecasts
5.2.1 By Application - Global PD-1 and PD-L1 Drug Revenue, 2019-2024
5.2.2 By Application - Global PD-1 and PD-L1 Drug Revenue, 2025-2030
5.2.3 By Application - Global PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
5.3 By Application - Global PD-1 and PD-L1 Drug Sales & Forecasts
5.3.1 By Application - Global PD-1 and PD-L1 Drug Sales, 2019-2024
5.3.2 By Application - Global PD-1 and PD-L1 Drug Sales, 2025-2030
5.3.3 By Application - Global PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
5.4 By Application - Global PD-1 and PD-L1 Drug Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global PD-1 and PD-L1 Drug Market Size, 2023 & 2030
6.2 By Region - Global PD-1 and PD-L1 Drug Revenue & Forecasts
6.2.1 By Region - Global PD-1 and PD-L1 Drug Revenue, 2019-2024
6.2.2 By Region - Global PD-1 and PD-L1 Drug Revenue, 2025-2030
6.2.3 By Region - Global PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
6.3 By Region - Global PD-1 and PD-L1 Drug Sales & Forecasts
6.3.1 By Region - Global PD-1 and PD-L1 Drug Sales, 2019-2024
6.3.2 By Region - Global PD-1 and PD-L1 Drug Sales, 2025-2030
6.3.3 By Region - Global PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America PD-1 and PD-L1 Drug Revenue, 2019-2030
6.4.2 By Country - North America PD-1 and PD-L1 Drug Sales, 2019-2030
6.4.3 US PD-1 and PD-L1 Drug Market Size, 2019-2030
6.4.4 Canada PD-1 and PD-L1 Drug Market Size, 2019-2030
6.4.5 Mexico PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe PD-1 and PD-L1 Drug Revenue, 2019-2030
6.5.2 By Country - Europe PD-1 and PD-L1 Drug Sales, 2019-2030
6.5.3 Germany PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5.4 France PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5.5 U.K. PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5.6 Italy PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5.7 Russia PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5.8 Nordic Countries PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5.9 Benelux PD-1 and PD-L1 Drug Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia PD-1 and PD-L1 Drug Revenue, 2019-2030
6.6.2 By Region - Asia PD-1 and PD-L1 Drug Sales, 2019-2030
6.6.3 China PD-1 and PD-L1 Drug Market Size, 2019-2030
6.6.4 Japan PD-1 and PD-L1 Drug Market Size, 2019-2030
6.6.5 South Korea PD-1 and PD-L1 Drug Market Size, 2019-2030
6.6.6 Southeast Asia PD-1 and PD-L1 Drug Market Size, 2019-2030
6.6.7 India PD-1 and PD-L1 Drug Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America PD-1 and PD-L1 Drug Revenue, 2019-2030
6.7.2 By Country - South America PD-1 and PD-L1 Drug Sales, 2019-2030
6.7.3 Brazil PD-1 and PD-L1 Drug Market Size, 2019-2030
6.7.4 Argentina PD-1 and PD-L1 Drug Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa PD-1 and PD-L1 Drug Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa PD-1 and PD-L1 Drug Sales, 2019-2030
6.8.3 Turkey PD-1 and PD-L1 Drug Market Size, 2019-2030
6.8.4 Israel PD-1 and PD-L1 Drug Market Size, 2019-2030
6.8.5 Saudi Arabia PD-1 and PD-L1 Drug Market Size, 2019-2030
6.8.6 UAE PD-1 and PD-L1 Drug Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Company Summary
7.1.2 Bristol Myers Squibb Business Overview
7.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Major Product Offerings
7.1.4 Bristol Myers Squibb PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.1.5 Bristol Myers Squibb Key News & Latest Developments
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Company Summary
7.2.2 Merck & Co., Inc. Business Overview
7.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Major Product Offerings
7.2.4 Merck & Co., Inc. PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.2.5 Merck & Co., Inc. Key News & Latest Developments
7.3 F. Hoffmann -La Roche Ltd
7.3.1 F. Hoffmann -La Roche Ltd Company Summary
7.3.2 F. Hoffmann -La Roche Ltd Business Overview
7.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Major Product Offerings
7.3.4 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.3.5 F. Hoffmann -La Roche Ltd Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca PD-1 and PD-L1 Drug Major Product Offerings
7.4.4 AstraZeneca PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi PD-1 and PD-L1 Drug Major Product Offerings
7.5.4 Sanofi PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.5.5 Sanofi Key News & Latest Developments
7.6 Pfizer Inc
7.6.1 Pfizer Inc Company Summary
7.6.2 Pfizer Inc Business Overview
7.6.3 Pfizer Inc PD-1 and PD-L1 Drug Major Product Offerings
7.6.4 Pfizer Inc PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.6.5 Pfizer Inc Key News & Latest Developments
7.7 Lilly
7.7.1 Lilly Company Summary
7.7.2 Lilly Business Overview
7.7.3 Lilly PD-1 and PD-L1 Drug Major Product Offerings
7.7.4 Lilly PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.7.5 Lilly Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG PD-1 and PD-L1 Drug Major Product Offerings
7.8.4 Novartis AG PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.8.5 Novartis AG Key News & Latest Developments
7.9 GSK
7.9.1 GSK Company Summary
7.9.2 GSK Business Overview
7.9.3 GSK PD-1 and PD-L1 Drug Major Product Offerings
7.9.4 GSK PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.9.5 GSK Key News & Latest Developments
7.10 Junshi Biosciences
7.10.1 Junshi Biosciences Company Summary
7.10.2 Junshi Biosciences Business Overview
7.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Major Product Offerings
7.10.4 Junshi Biosciences PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.10.5 Junshi Biosciences Key News & Latest Developments
7.11 Akeso, Inc
7.11.1 Akeso, Inc Company Summary
7.11.2 Akeso, Inc PD-1 and PD-L1 Drug Business Overview
7.11.3 Akeso, Inc PD-1 and PD-L1 Drug Major Product Offerings
7.11.4 Akeso, Inc PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.11.5 Akeso, Inc Key News & Latest Developments
7.12 BeiGene
7.12.1 BeiGene Company Summary
7.12.2 BeiGene PD-1 and PD-L1 Drug Business Overview
7.12.3 BeiGene PD-1 and PD-L1 Drug Major Product Offerings
7.12.4 BeiGene PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.12.5 BeiGene Key News & Latest Developments
7.13 Innovent
7.13.1 Innovent Company Summary
7.13.2 Innovent PD-1 and PD-L1 Drug Business Overview
7.13.3 Innovent PD-1 and PD-L1 Drug Major Product Offerings
7.13.4 Innovent PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.13.5 Innovent Key News & Latest Developments
7.14 Jiangsu Hengrui Medicine Co.,Ltd
7.14.1 Jiangsu Hengrui Medicine Co.,Ltd Company Summary
7.14.2 Jiangsu Hengrui Medicine Co.,Ltd Business Overview
7.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Major Product Offerings
7.14.4 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.14.5 Jiangsu Hengrui Medicine Co.,Ltd Key News & Latest Developments
7.15 Cstone
7.15.1 Cstone Company Summary
7.15.2 Cstone Business Overview
7.15.3 Cstone PD-1 and PD-L1 Drug Major Product Offerings
7.15.4 Cstone PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.15.5 Cstone Key News & Latest Developments
7.16 Henlius
7.16.1 Henlius Company Summary
7.16.2 Henlius Business Overview
7.16.3 Henlius PD-1 and PD-L1 Drug Major Product Offerings
7.16.4 Henlius PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.16.5 Henlius Key News & Latest Developments
7.17 Simcere Pharmaceutical Group Limited
7.17.1 Simcere Pharmaceutical Group Limited Company Summary
7.17.2 Simcere Pharmaceutical Group Limited Business Overview
7.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Major Product Offerings
7.17.4 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.17.5 Simcere Pharmaceutical Group Limited Key News & Latest Developments
8 Global PD-1 and PD-L1 Drug Production Capacity, Analysis
8.1 Global PD-1 and PD-L1 Drug Production Capacity, 2019-2030
8.2 PD-1 and PD-L1 Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global PD-1 and PD-L1 Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PD-1 and PD-L1 Drug Supply Chain Analysis
10.1 PD-1 and PD-L1 Drug Industry Value Chain
10.2 PD-1 and PD-L1 Drug Upstream Market
10.3 PD-1 and PD-L1 Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 PD-1 and PD-L1 Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer